Alpha 2.0
Login Register
» Authors » B Pohlman

B Pohlman

Explore the profile of B Pohlman including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 63
Citations 1340
Followers 0
Related Specialties
General Surgery
Oncology
Hematology
Top 10 Co-Authors
M Kalaycio
S Andresen
R Sobecks
L Rybicki
B Bolwell
R Dean
B J Bolwell
E Copelan
M Goormastic
J Sweetenham
Published In
Bone Marrow Transplant
Semin Oncol
Clin Lymphoma
Am J Clin Oncol
J Cancer Res Clin Oncol
Affiliations
Soon will be listed here.
Recent Articles
1.
Impact of cigarette smoking on survival after myeloablative allogeneic hematopoietic stem cell transplantation and contribution of invasive fungal infection
Mehdi A, Rybicki L, Mossad S, Yurch M, Sekeres M, Gerds A, et al.
Bone Marrow Transplant . 2017 Sep; 52(12):1665-1667. PMID: 28869614
No abstract available.
2.
GvHD-free, relapse-free survival after reduced-intensity allogeneic hematopoietic cell transplantation in older patients with myeloid malignancies
Nazha A, Rybicki L, Abounader D, Bolwell B, Dean R, Gerds A, et al.
Bone Marrow Transplant . 2016 Oct; 51(12):1642-1643. PMID: 27721371
No abstract available.
3.
Association of socioeconomic status with autologous hematopoietic cell transplantation outcomes for lymphoma
Hong S, Rybicki L, Abounader D, Bolwell B, Dean R, Gerds A, et al.
Bone Marrow Transplant . 2016 Apr; 51(9):1191-6. PMID: 27111046
Socioeconomic status (SES) is an important determinant of disparities in health care. The association of SES with outcomes in autologous hematopoietic cell transplantation (AHCT) has not been described previously. We...
4.
Outcomes of autologous hematopoietic cell transplantation in primary amyloidosis after bortezomib-based induction therapy
Hong S, Valent J, Rybicki L, Abounader D, Bolwell B, Dean R, et al.
Bone Marrow Transplant . 2016 Jan; 51(5):732-4. PMID: 26726941
No abstract available.
5.
Association of socioeconomic status with long-term outcomes in 1-year survivors of allogeneic hematopoietic cell transplantation
Fu S, Rybicki L, Abounader D, Andresen S, Bolwell B, Dean R, et al.
Bone Marrow Transplant . 2015 Jul; 50(10):1326-30. PMID: 26191953
The relationship of socioeconomic status (SES) with long-term outcomes in allogeneic hematopoietic cell transplantation (HCT) survivors has not been well described. We studied the association of SES with the outcomes...
6.
Prognostic significance of pre-transplant quality of life in allogeneic hematopoietic cell transplantation recipients
Hamilton B, Law A, Rybicki L, Abounader D, Dabney J, Dean R, et al.
Bone Marrow Transplant . 2015 Jun; 50(9):1235-40. PMID: 26030045
Quality of life (QOL) is an important outcome for hematopoietic cell transplantation (HCT) recipients. Whether pre-HCT QOL adds prognostic information to patient and disease related risk factors has not been...
7.
Risk factors for vancomycin-resistant enterococcus bacteremia and its influence on survival after allogeneic hematopoietic cell transplantation
Tavadze M, Rybicki L, Mossad S, Avery R, Yurch M, Pohlman B, et al.
Bone Marrow Transplant . 2014 Aug; 49(10):1310-6. PMID: 25111516
Vancomycin-resistant enterococcus (VRE) is a well-known infectious complication among immunocompromised patients. We performed a retrospective analysis to identify risk factors for the development of VRE bacteremia (VRE-B) within 15 months...
8.
Long-term follow-up of a prospective randomized trial comparing CYA and MTX with CYA and mycophenolate mofetil for GVHD prophylaxis in myeloablative sibling donor hematopoietic cell transplantation
Hamilton B, Bolwell B, Kalaycio M, Rybicki L, Hanna R, Sobecks R, et al.
Bone Marrow Transplant . 2013 Jun; 48(12):1578-80. PMID: 23749105
No abstract available.
9.
Intravenous compared with oral busulfan as preparation for allogeneic hematopoietic progenitor cell transplantation for AML and MDS
Sobecks R, Rybicki L, Yurch M, Kalaycio M, Dean R, Andresen S, et al.
Bone Marrow Transplant . 2011 Aug; 47(5):633-8. PMID: 21874055
BU and CY is a common conditioning regimen for allogeneic hematopoietic progenitor cell transplantation (HPCT). I.v. BU is increasingly used in place of the oral formulation for conditioning. We compared...
10.
Fludarabine as a risk factor for poor stem cell harvest, treatment-related MDS and AML in follicular lymphoma patients after autologous hematopoietic cell transplantation
Waterman J, Rybicki L, Bolwell B, Copelan E, Pohlman B, Sweetenham J, et al.
Bone Marrow Transplant . 2011 May; 47(4):488-93. PMID: 21572461
Fludarabine is an effective treatment for follicular lymphoma (FL), but exposure to it negatively impacts stem cell mobilization and may increase the risk of subsequent myelodysplastic syndrome and acute myelogenous...